The outcome of emergent balloon aortic valvuloplasty for cardiogenic shock due to severe aortic stenosis

Efficacy and safety of emergent balloon aortic valvuloplasty as rescue therapy for cardiogenic shock due to severe aortic stenosis - Efficacy and safety of emergent balloon aortic valvuloplasty as rescue therapy for cardiogenic shock due to severe aortic stenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054925

Enrollment

Registered

2024-07-10

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: This multi-center retrospective study in six non-TAVI centers included patients hospitalized for cardiogenic shock due to severe AS from January 2015 to July 2022.

Exclusion criteria

Exclusion criteria: The following shock status related to other causes except for severe AS were excluded from this study: acute coronary syndrome, tamponade, stress cardiomyopathy, pulmonary embolism, myocarditis, severe aortic regurgitation, severe mitral regurgitation/stenosis, or patients with concomitant sepsis or severe bleeding.

Design outcomes

Primary

Measure	Time frame
Thirty-day mortality and procedural complication rates	—

Secondary

Measure	Time frame
Days to withdraw from mechanical support device, the days to initial rehabilitation, and clinical frailty scale at discharge.	—

Countries

Japan

Contacts

Public ContactMasamichi Iwasaki

Hyogo Prefectural Awaji Medical Center Department of Cardiology

iwa_michi1114@yahoo.co.jp0799-22-1200

Outcome results